实用医学杂志 ›› 2021, Vol. 37 ›› Issue (8): 989-993.doi: 10.3969/j.issn.1006⁃5725.2021.08.006

• 基础研究 • 上一篇    下一篇

糖蛋白丝甘蛋白聚糖促进卵巢癌细胞的化疗耐药和转移

邓晓芳, 彭俊琴, 陈历排, 卢斌贵    

  1. 广州医科大学附属肿瘤医院1 内科二区,2 医学影像科,3 妇瘤科(广州 510095)

  • 出版日期:2021-04-25 发布日期:2021-04-25
  • 通讯作者: 彭俊琴 E⁃mail:523904694@qq.com
  • 基金资助:
    广东省医学科学技术研究基金资助项目(编号:c2017053)

Serglycin promotes chemoresistance and metastasis of epithelial ovarian cancer cells

DENG Xiaofang PENG Junqin,CHEN Lipai,LU Bingui.   

  1. Department of Second Division of Internal Medicine,Affiliated Cancer Hospital of Guangzhou Medical University,Guangzhou 510095,China

  • Online:2021-04-25 Published:2021-04-25
  • Contact: PENG Junqin E⁃mail:523904694@qq.com

摘要:

目的 探究糖蛋白丝甘蛋白聚糖(Serglycin)在卵巢癌化疗耐药及转移中的作用。方法 在卵巢癌 SKOV3 细胞株中,利用 shRNA 技术建立稳定干扰 Serglycin 细胞株;利用 MTS 方法检测敲低 Serglycin 的卵巢癌细胞株对化疗药物顺铂的药物敏感性及 Transwell 小室检测敲低 Serglycin 的卵巢癌细胞 株的侵袭转移能力;利用 Western Blot 及生物信息学检测分析 Serglycin EMT 相关分子的影响;进一步 通过 TCGA 卵巢癌数据集分析 Serglycin 与卵巢癌患者预后的相关性。结果 敲低 Serglycin 可明显增强卵 巢癌细胞对化疗药物顺铂的敏感性,明显抑制卵巢癌细胞侵袭转移能力,同时 Serglycin 可通过 ZEB2 促进 卵巢癌细胞的 EMT 改变,Serglycin 低表达明显延长卵巢癌患者总生存期(HR = 1.26,P<0.001)。结论 Serglycin 经EMT 改变促进卵巢癌细胞的化疗耐药和侵袭转移。

关键词:

Abstract:

Objective To explore the role of glycoprotein Serglycin in chemoresistance and metastasis of epithelial ovarian cancer. Methods The stable interference cell line was established from epithelial ovarian cancer SKOV3 cell line by interfering with Serglycin expression using shRNA technology,and Western blot technology and qRT ⁃PCR were employed to verify knockdown efficiency. MTS method was used to detect the sensitivity of ovarian cancer cell line with stable knockdown of Serglycin to the chemotherapeutic drug cisplatin. Transwell cell was used to detect the invasion and metastatic ability of ovarian cancer cell lines with stable knockdown of Serglycin;Western blot was used to detect the effect of Serglycin on EMT ⁃ related molecules. In addition,online prognosis analysis software(kmplot)was used to analyze the correlation between Serglycin and the prognosis of patients with epithelial ovarian cancer. Results Knockdown of Serglycin cells significantly enhanced the sensitivity of epithelial ovarian cancer cells to the chemotherapy drug cisplatin and significantly inhibited the invasion and metastasis ability of ep⁃ ithelial ovarian cancer cells compared with the control group. The knockdown promoted the EMT changes of epithelial ovarian cancer cells via ZEB2. The overall survival of the patients with low expression of Serglycin was significantly longer than those with high expression(HR = 1.26,P<0.001). Conclusion Serglycin promotes EMT changes of ovarian cancer cells via ZEB2,and then promotes chemoresistance and invasion and metastasis of ovarian cancer cells.

Key words: